-
1
-
-
0034673956
-
Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review
-
Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med 2000 16;132:810-819.
-
(2000)
Ann Intern Med
, vol.16
, Issue.132
, pp. 810-819
-
-
Nanda, K.1
McCrory, D.C.2
Myers, E.R.3
-
2
-
-
0024587108
-
The Papanicolaou test for cervical cancer detection. A triumph and a tragedy
-
Koss LG. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA 1989;261:737-743.
-
(1989)
JAMA
, vol.261
, pp. 737-743
-
-
Koss, L.G.1
-
3
-
-
33947649601
-
European guidelines for quality assurance in cervical cancer screening: Recommendations for cytology laboratories
-
Wiener HG, Klinkhamer P, Schenck U, et al. European guidelines for quality assurance in cervical cancer screening: recommendations for cytology laboratories. Cytopathology 2007;18:67-78.
-
(2007)
Cytopathology
, vol.18
, pp. 67-78
-
-
Wiener, H.G.1
Klinkhamer, P.2
Schenck, U.3
-
4
-
-
0031613238
-
-
Frable WJ, Austin RM, Greening SE, et al. Medicolegal affairs. International academy of cytology task force summary. Diagnostic cytology towards the 21st century: An international expert conference and tutorial. Acta Cytol 1998;42:76-119.
-
Frable WJ, Austin RM, Greening SE, et al. Medicolegal affairs. International academy of cytology task force summary. Diagnostic cytology towards the 21st century: An international expert conference and tutorial. Acta Cytol 1998;42:76-119.
-
-
-
-
5
-
-
27844511931
-
Alliance for cervical cancer prevention cost working group. Cost-effectiveness of cervical-cancer screening in five developing countries
-
Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, et al. Alliance for cervical cancer prevention cost working group. Cost-effectiveness of cervical-cancer screening in five developing countries. N Engl J Med 2005;353:2158-2168.
-
(2005)
N Engl J Med
, vol.353
, pp. 2158-2168
-
-
Goldie, S.J.1
Gaffikin, L.2
Goldhaber-Fiebert, J.D.3
-
6
-
-
33846632806
-
CHAPTER 7 Methods for detection of HPV infection and its clinical utility
-
Villa LL, Denny L. CHAPTER 7 Methods for detection of HPV infection and its clinical utility. Int J Gynaecol Obstet 2006;94 (Suppl 1):S71-S80.
-
(2006)
Int J Gynaecol Obstet
, vol.94
, Issue.SUPPL. 1
-
-
Villa, L.L.1
Denny, L.2
-
7
-
-
33947508568
-
-
Bibbo M, Akerman M, Alves VAF, et al. How technology is reshaping the practice of nongynecologic cytology frontiers of cytology symposium. Acta Cytol 2007;51:123-152.
-
Bibbo M, Akerman M, Alves VAF, et al. How technology is reshaping the practice of nongynecologic cytology frontiers of cytology symposium. Acta Cytol 2007;51:123-152.
-
-
-
-
8
-
-
0142062143
-
Primary screening of cervical cancer with human papillomavirus tests
-
Franco EL. Primary screening of cervical cancer with human papillomavirus tests. J Natl Cancer Inst Monogr 2003;31:89-96.
-
(2003)
J Natl Cancer Inst Monogr
, vol.31
, pp. 89-96
-
-
Franco, E.L.1
-
9
-
-
33745267064
-
New technologies for cervical cancer working group. Human papillomavirus testing and liquid-based cytology: Results at recruitment from the new technologies for cervical cancer randomized controlled trial
-
Ronco G, Segnan N, Giorgi-Rossi P, et al. New technologies for cervical cancer working group. Human papillomavirus testing and liquid-based cytology: Results at recruitment from the new technologies for cervical cancer randomized controlled trial. J Natl Cancer Inst 2006;98:765-774.
-
(2006)
J Natl Cancer Inst
, vol.98
, pp. 765-774
-
-
Ronco, G.1
Segnan, N.2
Giorgi-Rossi, P.3
-
10
-
-
33745104064
-
Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: Experience from the Latin American Screening study
-
Longatto-Filho A, Erzen M, Branca M, et al. Human papillomavirus testing as an optional screening tool in low-resource settings of Latin America: Experience from the Latin American Screening study. Int J Gynecol Cancer 2006;16:955-962.
-
(2006)
Int J Gynecol Cancer
, vol.16
, pp. 955-962
-
-
Longatto-Filho, A.1
Erzen, M.2
Branca, M.3
-
11
-
-
33751164570
-
The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive cytologically normal women over a 10-year period
-
Kjaer S, Hogdall E, Frederiksen K, et al. The absolute risk of cervical abnormalities in high-risk human papillomavirus-positive cytologically normal women over a 10-year period. Cancer Res 2006; 66:10630-10636.
-
(2006)
Cancer Res
, vol.66
, pp. 10630-10636
-
-
Kjaer, S.1
Hogdall, E.2
Frederiksen, K.3
-
12
-
-
33746349573
-
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
-
Cuzick J, Clavel C, Perry KU, et al. Overview of the European and North American studies on HPV testing in primary cervical cancer screening. Int J Cancer 2006;119:1095-1101.
-
(2006)
Int J Cancer
, vol.119
, pp. 1095-1101
-
-
Cuzick, J.1
Clavel, C.2
Perry, K.U.3
-
13
-
-
33747892271
-
-
Franco EL, Cuzick J, Hildesheim A, De Sanjose S. Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination. Vaccine 2006;24S3:S3171-S3177.
-
Franco EL, Cuzick J, Hildesheim A, De Sanjose S. Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination. Vaccine 2006;24S3:S3171-S3177.
-
-
-
-
14
-
-
33846459369
-
American cancer society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors
-
Saslow D, Castle PE, Cox JT, et al. American cancer society guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007;57:7-28.
-
(2007)
CA Cancer J Clin
, vol.57
, pp. 7-28
-
-
Saslow, D.1
Castle, P.E.2
Cox, J.T.3
-
15
-
-
33847613463
-
Cervical cancer prevention for all the world's women: Genuine promise resides in skilled quality management rather than novel screening approaches
-
Suba EJ, Donnelly AD, Furia LM, Huynh MLD, Raab SS. Cervical cancer prevention for all the world's women: genuine promise resides in skilled quality management rather than novel screening approaches. Diagn Cytopathol 2007;35:187-191.
-
(2007)
Diagn Cytopathol
, vol.35
, pp. 187-191
-
-
Suba, E.J.1
Donnelly, A.D.2
Furia, L.M.3
Huynh, M.L.D.4
Raab, S.S.5
-
16
-
-
33847117586
-
Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: Projections from the National Health Interview Survey (NHIS)
-
Eltoum IA, Roberson J. Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: Projections from the National Health Interview Survey (NHIS). Cancer Cytopathology 2007;11:34-40.
-
(2007)
Cancer Cytopathology
, vol.11
, pp. 34-40
-
-
Eltoum, I.A.1
Roberson, J.2
|